This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Imaging Breast Implant Rupture Dr Pierre Vassallo - Breast augmentation is the most common form ... (18 May 2018)
The 39th World Medical & Health Games ... Sports Director Pierre Chicco talks Medigames with TheSynapse. ... (18 May 2018)
Maddy's Pandora: Cherry Blossoms and ... Michelle Muscat   i2i Publishing; 200 pages; £8.95 ... (18 May 2018)
Is this disseminated ovarian cancer or not? Short accounts of interesting cases, some medical disasters, ... (18 May 2018)
Rare diseases - why bother? Dr Frans Agius   (18 May 2018)
Thursday, 08 February 2018 22:08

Re-Introducing an ‘Old’ Antibiotic May Help Fight Multi-Drug Resistant Bacteria Featured

Rate this item
(0 votes)

A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections. In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment of uncomplicated cystitis; however the Pharmacology Research & Perspectives study found that a dosing regimen of 6–12 grams per day divided in 3 doses is required for the treatment of systemic multi-drug-resistant bacterial infections.

Fosfomycin—an ‘old’ antibiotic that was developed more than 40 years ago—is a broad spectrum antibiotic that inhibits the early stages of the bacterial cell wall synthesis.

“Importantly, we show that there is a viable alternative to the lengthy and thus costly development of new antibiotics. The often scattered knowledge in literature and in the clinic is waiting to be combined and can be used immediately in a confirmatory clinical trial,” said senior author Dr. Jasper Stevens, of the University Medical Center Groningen, in The Netherlands.


Source: Wiley
Full bibliographic information:
Natalia V. Ortiz Zacaras, Anneke C. Dijkmans, Jacobus Burggraaf, Johan W. Mouton, Erik B. Wilms, Cees van Nieuwkoop, Daan J. Touw, Ingrid M. C. Kamerling and Jasper Stevens. Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens. Pharmacology Research & Perspectives.

Read 421 times Last modified on Friday, 09 February 2018 18:29

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

  • WASP Course in Bahrain

    WASP Course, led by Prof Victor Grech and Prof Charles Savona Ventura, has recently organised a course in Bahrain. Co-hosted with Arabian Gulf University, the course, on how to write a scientific paper, focused on quantitative analysis methods and was targeted for medical doctors and allied health professionals.

    Written on April 24, 2018 Read more...

SPONSOR MESSAGE

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…